Propofol may protect PC12 cells from β-amyloid25-35 induced apoptosis through the GSK-3β signaling pathway

Chinese Medical Journal

Volumn 126, Issue 10, 2013, Pages 1884-1889

  Zhang, Rui ^a   Xu, Jie ^b   Liu, Yan Yong ^c   Zuo, Ping Ping ^c   Yang, Nan ^c   Ji, Chao ^c   Wang, Yun ^b   Wang, Hui ^b   Wu, An Shi ^b   Yue, Yun ^b  

^a WEIFANG MEDICAL UNIVERSITY   (China)

^b CAPITAL MEDICAL UNIVERSITY   (China)

^c INSTITUTE OF BASIC MEDICAL SCIENCES   (China)

Author keywords

amyloid; Alzheimer's disease; Bcl 2 bax; GSK 3 ; Propofol; Tau protein

Indexed keywords

3 (4, 5 DIMETHYL 2 THIAZOLYL) 2, 5 DIPHENYLTETRAZOLIUM BROMIDE; AMYLOID BETA PROTEIN; PROPOFOL; PROTEIN BCL 2; PROTEIN KINASE; TAU PROTEIN; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CELL CULTURE; CELL PROTECTION; CELL SURVIVAL; CELL VIABILITY; CONTROLLED STUDY; DOSE RESPONSE; IMMUNOCYTOCHEMISTRY; IMMUNOHISTOCHEMISTRY; OPTICAL DENSITY; PC12 CELL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; SURVIVAL RATE; WESTERN BLOTTING;

AMYLOID BETA-PEPTIDES; ANIMALS; APOPTOSIS; CELL SURVIVAL; GLYCOGEN SYNTHASE KINASE 3; PC12 CELLS; PEPTIDE FRAGMENTS; PHOSPHORYLATION; PROPOFOL; RATS; SIGNAL TRANSDUCTION;

EID: 84877853341     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.0366-6999.20130095     Document Type: Article

References (25)

1. Kawahara M, Kuroda Y. Molecular mechanism of neurode-generation induced by Alzheimer's beta-amyloid protein: channel formation and disruption of calcium homeostasis. Brain Res Bull 2000; 53: 389-397.
2. Selkoe DJ. Images in neuroscience. Alzheimer's disease: from genes to pathogenesis. Am J Psychiatry 1997; 154: 1198.
3. Wu WS, Zhao YS, Shi ZH, Chang SY, Nie GJ, Duan XL, et al. Mitochondrial ferritin attenuates β-amyloid-induced neurotoxicity: reduction in oxidative damage through the ERK/ p38 mitogen-activated protein kinase pathways. Antioxid Redox Signal 2013; 18: 158-169.
4. Wang LC, Wang SE, Wang JJ, Tsai TY, Lin CH, Pan TM, et al. In vitro and in vivo comparisons of the effects of the fruiting body and mycelium of Antrodia camphorata against amyloid β-protein-induced neurotoxicity and memory impairment. Appl Microbiol Biotechnol 2012; 94: 1505-1519.
5. Xing XN, Zhang WG, Sha S, Li Y, Guo R, Wang C, et al. Amyloid β 3-10 DNA vaccination suggests a potential new treatment for Alzheimer's disease in BALB/c mice. Chin Med J 2011; 124: 2636-2641.
6. Karch CM, Jeng AT, Goate AM. Extracellular tau levels are influenced by variability in tau that is associated with tauopathies. J Biol Chem 2012; 287: 42751-42762.
7. Takata K, Kitamura Y. Molecular approaches to the treatment, prophylaxis, and diagnosis of Alzheimer's disease: tangle formation, amyloid-β, and microglia in Alzheimer's disease. J Pharmacol Sci 2012; 118: 331-337.
8. Li L, Hölscher C. Common pathological processes in Alzheimer disease and type 2 diabetes: a review. Brain Res Rev 2007; 56: 384-402.
9. Fath T, Eidenmüller J, Brandt R. Tau-mediated cytotoxicity in a pseudohyperphosphorylation model of Alzheimer's disease. J Neurosci 2002; 22: 9733-9741.
10. Leschik J, Welzel A, Weissmann C, Eckert A, Brandt R. Inverse and distinct modulation of tau-dependent neurodegeneration by presenilin 1 and amyloid-beta in cultured cortical neurons: evidence that tau phosphorylation is the limiting factor in amyloid-beta-induced cell death. J Neurochem 2007; 101: 1303-1315.
11. Harman F, Hasturk AE, Yaman M, Arca T, Kilinc K, Sargon MF, et al. Neuroprotective effects of propofol, thiopental, etomidate, and midazolam in fetal rat brain in ischemia-reperfusion model. Childs Nerv Syst 2012; 28: 1055-1062.
12. Kelly BL, Ferreira A. beta-Amyloid-induced dynamin 1 degradation is mediated by N-methyl-D-aspartate receptors in hippocampal neurons. J Biol Chem 2006; 281: 28079-28089.
13. Walsh DM, Selkoe DJ. Deciphering the molecular basis of memory failure in Alzheimer's disease. Neuron 2004; 44: 181-193.
14. Churcher I. Tau therapeutic strategies for the treatment of Alzheimer's disease. Curr Top Med Chem 2006; 6: 579-595.
15. Bulic B, Pickhardt M, Schmidt B, Mandelkow EM, Waldmann H, Mandelkow E. Development of tau aggregation inhibitors for Alzheimer's disease. Angew Chem Int Ed Engl 2009; 48: 1740-1752.
16. Iqbal K, Alonso Adel C, El-Akkad E, Gong CX, Haque N, Khatoon S, et al. Alzheimer neurofibrillary degeneration: therapeutic targets and high-throughput assays. J Mol Neurosci 2003; 20: 425-429.
17. Inada T, Kubo K, Shingu K. Possible link between cyclooxygenase-inhibiting and antitumor properties of propofol. J Anesth 2011; 25: 569-575.
18. Kotani Y, Shimazawa M, Yoshimura S, Iwama T, Hara H. The experimental and clinical pharmacology of propofol, an anesthetic agent with neuroprotective properties. CNS Neurosci Ther 2008; 14: 95-106.
19. Corcoran TB, O'Shea A, Engel A, Shorten GD. The influence of propofol on P-selectin expression and nitric oxide production in re-oxygenated human umbilical vein endothelial cells. Acta Anaesthesiol Scand 2006; 50: 348-354.
20. Li H, Tan J, Zou Z, Huang CG, Shi XY. Propofol post-conditioning protects against cardiomyocyte apoptosis in hypoxia/reoxygenation injury by suppressing nuclear factor-kappa B translocation via extracellular signal-regulated kinase mitogen-activated protein kinase pathway. Eur J Anaesthesiol 2011; 28: 525-534.
21. Whittington RA, Virág L, Marcouiller F, Papon MA, El Khoury NB, Julien C, et al. Propofol directly increases tau phosphorylation. PLoS One 2011; 31: 16648.
22. Xu J, Zhang R, Zuo P, Yang N, Ji C, Liu W, et al. Aggravation effect of isoflurane on Aβ25-35-induced apoptosis and tau hyperphosphorylation in PC12 cells. Cell Mol Neurobiol 2012; 32: 1343-1351.
23. Li HY, Yuan ZY, Wang YG, Wan HJ, Hu J, Chai YS, et al. Role of baicalin in regulating Toll-like receptor 2/4 after ischemic neuronal injury. Chin Med J 2012; 125: 1586-1593.
24. Ge YS, Teng WY, Zhang CD. Protective effect of cyclophilin A against Alzheimer's amyloid beta-peptide (25-35)-induced oxidative stress in PC12 cells. Chin Med J 2009; 122: 716-724.
25. Yu W, Mechawar N, Krantic S, Quirion R. Evidence for the involvement of apoptosis-inducing factor-mediated caspase-independent neuronal death in Alzheimer disease. Am J Pathol 2010; 176: 2209-2218.